Galectin Therapeutics Inc (GALT) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
2.33%3.98 | 4.08 | 3.37 | 4.20 | 4.63 | |
| Research and Development | 4.30%2.14 | 2.23 | 1.93 | 2.61 | 3.26 |
| Operating Income/Loss | 2.33%-3.98 | -4.08 | -3.37 | -4.20 | -4.63 |
| Nonoperating Income/Loss | 429.51%-5.13 | -0.97 | -2.14 | -3.99 | -2.90 |
80.60%-9.11 | -5.05 | -5.50 | -8.18 | -7.52 | |
| Attributable To Parent | 80.60%-9.11 | -5.05 | -5.50 | -8.18 | -7.52 |
| Available To Common Stockholders, Basic | 81.07%-9.18 | -5.07 | -5.56 | -8.22 | -7.58 |
| Preferred Stock Dividends And Other Adjustments | 195.24%0.06 | 0.02 | 0.06 | 0.04 | 0.06 |
| Basic Average Shares | 0.14%65.88 | 65.78 | - | 64.21 | 63.45 |
| Diluted Average Shares | 0.14%65.88 | 65.78 | - | 64.21 | 63.45 |
| Basic Earnings Per Share | 75.00%-0.14 | -0.08 | - | -0.13 | -0.12 |
| Diluted Earnings Per Share | 75.00%-0.14 | -0.08 | - | -0.13 | -0.12 |